0001209191-18-017175.txt : 20180306 0001209191-18-017175.hdr.sgml : 20180306 20180306152111 ACCESSION NUMBER: 0001209191-18-017175 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180305 FILED AS OF DATE: 20180306 DATE AS OF CHANGE: 20180306 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kamal Mostafa CENTRAL INDEX KEY: 0001647234 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-06639 FILM NUMBER: 18669681 MAIL ADDRESS: STREET 1: 15950 NORTH 76TH STREET, #200 CITY: SCOTTSDALE STATE: AZ ZIP: 85260 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MAGELLAN HEALTH INC CENTRAL INDEX KEY: 0000019411 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOSPITALS [8060] IRS NUMBER: 581076937 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4800 N. SCOTTSDALE ROAD STREET 2: SUITE 4400 CITY: SCOTTSDALE STATE: AZ ZIP: 85251 BUSINESS PHONE: 602-572-6050 MAIL ADDRESS: STREET 1: 4800 N. SCOTTSDALE ROAD STREET 2: SUITE 4400 CITY: SCOTTSDALE STATE: AZ ZIP: 85251 FORMER COMPANY: FORMER CONFORMED NAME: MAGELLAN HEALTH SERVICES INC DATE OF NAME CHANGE: 19960226 FORMER COMPANY: FORMER CONFORMED NAME: CHARTER MEDICAL CORP DATE OF NAME CHANGE: 19920703 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-03-05 0 0000019411 MAGELLAN HEALTH INC MGLN 0001647234 Kamal Mostafa 15950 NORTH 76TH STREET SUITE 200 SCOTTSDALE AZ 85260 0 1 0 0 CEO, Magellan Rx Management Ordinary Common Stock, $0.01 par value 2018-03-05 4 X 0 1480 63.95 A 1480 D Ordinary Common Stock, $0.01 par value 2018-03-05 4 X 0 7307 64.87 A 8787 D Ordinary Common Stock, $0.01 par value 2018-03-05 4 X 0 6641 68.50 A 15428 D Ordinary Common Stock, $0.01 par value 2018-03-05 4 S 0 15428 99.0386 D 0 D Stock Option (right to buy) 63.95 2018-03-05 4 X 0 1480 0.00 D 2025-03-03 Common Stock 1480 0 D Stock Option (right to buy) 64.87 2018-03-05 4 X 0 7307 0.00 D 2026-03-03 Common Stock 7307 7306 D Stock Option (right to buy) 68.50 2018-03-05 4 X 0 6641 0.00 D 2027-03-03 Common Stock 6641 13282 D This transaction was effectuated pursuant to a Rule 10b-5-1 Plan. The number of securities reported represents an aggregate number of shares sold in multiple open market transactions at prices ranging from $98.30 to $101.05, inclusive. The price reported represents the weighted average price. The Reporting Person undertakes to provide staff of the SEC, the issuer, or a stockholder of the issuer, upon request, the number of shares sold by the Reporting Person at each separate price within the range. All of the stock options in this tranche have vested in full. Not applicable. The remainder of 7,306 options shall vest on March 3, 2019. The remainder of 13,282 options shall vest in equal increments on March 3, 2019 and 2020. /s/ Mostafa Kamal 2018-03-06